Authorizes the use of opioid antagonists by public accommodations for opioid overdose prevention
Summary
Authorizes the use of opioid antagonists by persons or entities for opioid overdose prevention; defines "entity".
Bill status
signed
all 5 stages cleared
Introduction
May 2019
Committee Review
Mar 2020
Assembly Passage
Mar 2020
Senate Passage
Jul 2020
Signed into Law
Aug 2020
Introduced May 23, 2019
Signed Aug 24, 2020
Floor votes · Senate Jul 22, 2020 · Assembly Mar 2, 2020
How they voted
60–0
Passed
Total votes 60
Jul 22, 2020
D
Democratic40
100% Yea
R
Republican20
100% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
16
Key actions
3
Committee
5
Amendments
1
Aug 24, 2020
Signed into law
SIGNED CHAP.148
Jul 22, 2020
Senate · Passed
PASSED SENATE
Mar 2, 2020
Senate · Referred to committee
REFERRED TO HEALTH
Mar 2, 2020
Assembly · Passed
PASSED ASSEMBLY
Feb 4, 2020
Assembly · Referred to committee
REPORTED REFERRED TO CODES
Jan 28, 2020
Assembly · Amendment adopted
PRINT NUMBER 7812A
Jan 28, 2020
Assembly · Referred to committee
AMEND (T) AND RECOMMIT TO HEALTH
Jan 8, 2020
Assembly · Referred to committee
REFERRED TO HEALTH
May 23, 2019
Assembly · Referred to committee
REFERRED TO HEALTH
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about A 7812
Scope: NY
Hi! I can help you understand A 7812. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline